Brand profile · Biotechnology Research

Percheron Therapeutics Limited

Percheron Therapeutics Limited is a Biotechnology Research brand in Melbourne, Victoria. Ownership is publicly held; it publishes at percherontx.com. It holds one address on record, all in Australia. The record counts 9 people. One Australian registration (ABN) is a candidate match. It is listed alongside nine similar brands, mostly in Biotechnology Research.

Profile live Public Company Founded 2000 1 registry match ABN 1 office country
Registry match · ABR

Key facts

Counted staff
9
self-reported 2–10 band
Founded
2000
26 years
Registry matches
1
ABR
Office countries
1
1 address
Funding rounds
None on record
Company type
Public Company
self-reported
Use this profile Compare Your shortlist

Legal entity

1 brand → 1 possible registrationThese are name matches on ABR. 1 registration share this brand's name; which one you contract with is a question for the register.
  • PERCHERON THERAPEUTICS LIMITED

    ABN41095060745

    VICMedium confidenceMatched on exact nameABR

Legal entities

Percheron Therapeutics Limited: 1 registry entityPercheron Therapeutics Limited is linked to 1 registry entity: PERCHERON THERAPEUTICS LIMITED (ABN 41095060745, candidate).Percheron Therapeutics LimitedPERCHERON THERAPEUTICSLIMITEDABN 41095060745Candidate · Medium confidence
Show as table · Percheron Therapeutics Limited: 1 registry entity
Percheron Therapeutics Limited: 1 registry entity
PERCHERON THERAPEUTICS LIMITEDABN 41095060745
Confirmed matches0 of 1

A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.

Description

Percheron Therapeutics Limited (ASX: PER) is an international biotechnology company focused on the development of novel therapies for rare diseases.

The company’s lead program is ATL1102, an antisense oligonucleotide targeting the CD49d receptor. ATL1102 is currently the subject of an ongoing international phase IIb clinical trial for the treatment of non-ambulant patients with Duchenne Muscular Dystrophy (DMD), for which data is expected in 2H CY2024. The drug has previously reported promising results from an exploratory phase IIa study in the same population and has been awarded orphan drug designation (ODD) and rare pediatric disease designation (RPDD) by the US FDA.

For more information, please contact info@PercheronTx.com.

Locations

Country footprint

Offices in 1 countryCountry footprint: 1 country, primary AU. Codes: AU.1 countryprimary AUAU
Show as table · Offices in 1 country
Offices in 1 country
Countries1
Primary countryAU

All codes: AU

Addresses

  • AUL30, 35 Collins Street; Melbourne, Victoria 3000Primary

Grid intelligence Members

Spending power

TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.

Spending power

Signals & hiring

Hiring, headcount and registry-change signals, streamed to members.

Latest signal
Hiring activity
Headcount trend

Financials

Registry-filed capital and financial indicators, standardised by TheGrid.

Paid-up capital
Fiscal period
Registered charges
Revenue
Profit / loss

People & contacts

4 employee profiles on record · names withheld.

Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.

Counts only. No names are stored here, and none are served.

Notify me about contacts Tell us who you need to reach and we will tell you when a consented source is live.

FAQ

Which legal entity operates under Percheron Therapeutics Limited?

One Victoria entity on the ABR. PERCHERON THERAPEUTICS LIMITED (ABN 41 095 060 745), medium confidence.

How many people work at Percheron Therapeutics Limited?

The record holds 9 counted staff profiles at January 2026, inside the self-reported 2–10 band.

Where does Percheron Therapeutics Limited have offices?

One address on record, Australia only. Primary: L30, 35 Collins Street, Melbourne, Victoria 3000.

Has Percheron Therapeutics Limited raised funding?

None linked to this brand.

Which companies are listed alongside Percheron Therapeutics Limited?

7 profiles list Percheron Therapeutics Limited as a peer — 73rd percentile in Biotechnology Research. It lists ten peers of its own. Currus Biologics Pty Ltd and Aculeus Therapeutics list it back.

What is Percheron Therapeutics Limited's website?